Description
A well-established inhibitor of the NADP+-dependent enzyme, 6-phosphogluconate dehydrogenase (Ki = 0.46 μM) which interferes with glycolysis; through ATP depletion, synergizes with chemotherapy drugs, like cisplatin, in killing cancer cells (IC50 = 0.5 mM); reduces cardiovascular oxidative injury following ischemia/reperfusion; causes glial neurodegeneration,
Formal name: 6-amino-3-pyridinecarboxamide
Synonyms: 6-AN|NSC 21206|SR 4388
Molecular weight: 137.1
CAS: 329-89-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Metabolism||Research Area|Cardiovascular System|Cardiovascular Diseases|Myocardial Infarction||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Neuroscience